206 related articles for article (PubMed ID: 24126361)
61. Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response.
Her Z; Teng TS; Tan JJ; Teo TH; Kam YW; Lum FM; Lee WW; Gabriel C; Melchiotti R; Andiappan AK; Lulla V; Lulla A; Win MK; Chow A; Biswas SK; Leo YS; Lecuit M; Merits A; Rénia L; Ng LF
EMBO Mol Med; 2015 Jan; 7(1):24-41. PubMed ID: 25452586
[TBL] [Abstract][Full Text] [Related]
62. High throughput proteomic analysis and a comparative review identify the nuclear chaperone, Nucleophosmin among the common set of proteins modulated in Chikungunya virus infection.
Abraham R; Mudaliar P; Jaleel A; Srikanth J; Sreekumar E
J Proteomics; 2015 Apr; 120():126-41. PubMed ID: 25782748
[TBL] [Abstract][Full Text] [Related]
63. Chikungunya virus infection induces differential inflammatory and antiviral responses in human monocytes and monocyte-derived macrophages.
Felipe VLJ; Paula A V; Silvio UI
Acta Trop; 2020 Nov; 211():105619. PubMed ID: 32634389
[TBL] [Abstract][Full Text] [Related]
64. Correlation of phylogenetic clade diversification and in vitro infectivity differences among Cosmopolitan genotype strains of Chikungunya virus.
Abraham R; Manakkadan A; Mudaliar P; Joseph I; Sivakumar KC; Nair RR; Sreekumar E
Infect Genet Evol; 2016 Jan; 37():174-84. PubMed ID: 26611825
[TBL] [Abstract][Full Text] [Related]
65. Chikungunya Virus-Encoded nsP2, E2 and E1 Strongly Antagonize the Interferon-β Signaling Pathway.
Bae S; Lee JY; Myoung J
J Microbiol Biotechnol; 2019 Nov; 29(11):1852-1859. PubMed ID: 31635445
[TBL] [Abstract][Full Text] [Related]
66. Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock.
Rudd PA; Wilson J; Gardner J; Larcher T; Babarit C; Le TT; Anraku I; Kumagai Y; Loo YM; Gale M; Akira S; Khromykh AA; Suhrbier A
J Virol; 2012 Sep; 86(18):9888-98. PubMed ID: 22761364
[TBL] [Abstract][Full Text] [Related]
67. Molecular Epidemiology, Evolution and Reemergence of Chikungunya Virus in South Asia.
Sharif N; Sarkar MK; Ferdous RN; Ahmed SN; Billah MB; Talukder AA; Zhang M; Dey SK
Front Microbiol; 2021; 12():689979. PubMed ID: 34163459
[TBL] [Abstract][Full Text] [Related]
68. Cell-based analysis of Chikungunya virus E1 protein in membrane fusion.
Kuo SC; Chen YJ; Wang YM; Tsui PY; Kuo MD; Wu TY; Lo SJ
J Biomed Sci; 2012 Apr; 19(1):44. PubMed ID: 22520648
[TBL] [Abstract][Full Text] [Related]
69. Characterization of synthetic Chikungunya viruses based on the consensus sequence of recent E1-226V isolates.
Scholte FE; Tas A; Martina BE; Cordioli P; Narayanan K; Makino S; Snijder EJ; van Hemert MJ
PLoS One; 2013; 8(8):e71047. PubMed ID: 23936484
[TBL] [Abstract][Full Text] [Related]
70. Deciphering the differential response of two human fibroblast cell lines following Chikungunya virus infection.
Thon-Hon VG; Denizot M; Li-Pat-Yuen G; Giry C; Jaffar-Bandjee MC; Gasque P
Virol J; 2012 Sep; 9():213. PubMed ID: 22992396
[TBL] [Abstract][Full Text] [Related]
71. Micafungin is a novel anti-viral agent of chikungunya virus through multiple mechanisms.
Ho YJ; Liu FC; Yeh CT; Yang CM; Lin CC; Lin TY; Hsieh PS; Hu MK; Gong Z; Lu JW
Antiviral Res; 2018 Nov; 159():134-142. PubMed ID: 30300716
[TBL] [Abstract][Full Text] [Related]
72. Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate.
Gardner CL; Burke CW; Higgs ST; Klimstra WB; Ryman KD
Virology; 2012 Apr; 425(2):103-12. PubMed ID: 22305131
[TBL] [Abstract][Full Text] [Related]
73. Chikungunya virus induces IPS-1-dependent innate immune activation and protein kinase R-independent translational shutoff.
White LK; Sali T; Alvarado D; Gatti E; Pierre P; Streblow D; Defilippis VR
J Virol; 2011 Jan; 85(1):606-20. PubMed ID: 20962078
[TBL] [Abstract][Full Text] [Related]
74. Importation of a novel Indian Ocean lineage carrying E1-K211E and E2-V264A of Chikungunya Virus in Zhejiang Province, China, in 2019.
Su L; Lou X; Yan H; Yang Z; Mao H; Yao W; Sun Y; Pan J; Zhang Y
Virus Genes; 2023 Oct; 59(5):693-702. PubMed ID: 37468826
[TBL] [Abstract][Full Text] [Related]
75. Northward movement of East Central South African genotype of Chikungunya virus causing an epidemic between 2006-2010 in India.
Singh P; Mittal V; Rizvi MA; Bhattacharya D; Chhabra M; Rawat DS; Ichhpujani RL; Chauhan LS; Rai A
J Infect Dev Ctries; 2012 Jul; 6(7):563-71. PubMed ID: 22842943
[TBL] [Abstract][Full Text] [Related]
76. New Insights into Chikungunya Virus Infection and Pathogenesis.
Kril V; Aïqui-Reboul-Paviet O; Briant L; Amara A
Annu Rev Virol; 2021 Sep; 8(1):327-347. PubMed ID: 34255544
[TBL] [Abstract][Full Text] [Related]
77. Infection of myofibers contributes to increased pathogenicity during infection with an epidemic strain of chikungunya virus.
Rohatgi A; Corbo JC; Monte K; Higgs S; Vanlandingham DL; Kardon G; Lenschow DJ
J Virol; 2014 Mar; 88(5):2414-25. PubMed ID: 24335291
[TBL] [Abstract][Full Text] [Related]
78. Critical role for bone marrow stromal antigen 2 in acute Chikungunya virus infection.
Mahauad-Fernandez WD; Jones PH; Okeoma CM
J Gen Virol; 2014 Nov; 95(Pt 11):2450-2461. PubMed ID: 25053563
[TBL] [Abstract][Full Text] [Related]
79. TLR4 is one of the receptors for Chikungunya virus envelope protein E2 and regulates virus induced pro-inflammatory responses in host macrophages.
Mahish C; De S; Chatterjee S; Ghosh S; Keshry SS; Mukherjee T; Khamaru S; Tung KS; Subudhi BB; Chattopadhyay S; Chattopadhyay S
Front Immunol; 2023; 14():1139808. PubMed ID: 37153546
[TBL] [Abstract][Full Text] [Related]
80. Fatty acid synthase and stearoyl-CoA desaturase-1 are conserved druggable cofactors of Old World Alphavirus genome replication.
Bakhache W; Neyret A; McKellar J; Clop C; Bernard E; Weger-Lucarelli J; Briant L
Antiviral Res; 2019 Dec; 172():104642. PubMed ID: 31678479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
